StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
RAPH

Raphael Pharmaceutical Inc.

RAPH OTC Medicinal Chemicals & Botanical Products EDGAR ↗
$1.40
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$28.2M
Revenue (TTM)
Net income (TTM)
-$1.08M
EPS (TTM)
$0.06
P/E ratio
23.3
Dividend yield
Free cash flow
-$212K
Cash
$1.00K
Total assets
$3.00K
Gross margin
52-week range
$0.22 – $1.40

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change Jul 17, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Director or officer change Mar 24, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change Aug 11, 2025 8-K Other events Aug 11, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change Jan 14, 2025 8-K Other events Dec 30, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Changed accountants Sep 11, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Amended charter or bylaws Jun 26, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Other events May 2, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 10-K/A Fiscal year ended 2022-12-31 May 25, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 8-K Other events Mar 28, 2023 10-K Fiscal year ended 2022-12-31 Mar 24, 2023 8-K/A Director or officer change Jan 26, 2023 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Other events Oct 24, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Changed accountants; Director or officer change Jul 7, 2022 10-Q Quarter ended 2022-03-31 May 16, 2022 10-K Fiscal year ended 2021-12-31 Mar 30, 2022 10-Q Quarter ended 2021-09-30 Nov 16, 2021 8-K Changed accountants May 29, 2013 10-Q Quarter ended 2010-09-30 Nov 12, 2010 8-K Unregistered sale of equity; Director or officer change Oct 5, 2010 8-K Director or officer change Aug 25, 2010 10-Q Quarter ended 2010-06-30 Aug 6, 2010 10-Q Quarter ended 2010-03-31 May 14, 2010 10-K Fiscal year ended 2009-12-31 Apr 19, 2010